Trials / Recruiting
RecruitingNCT05754008
Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
A Randomized Trial of Care Navigator to Support Younger Latinx Adults Newly Diagnosed With Type 2 Diabetes (AURORA)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 204 (estimated)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 21 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The study proposes to rigorously evaluate a proactive, culturally responsive care navigator intervention targeting younger-onset Latinx individuals with a new T2D diagnosis (AURORA \[Active Outreach to Younger Latinx\]) within Kaiser Permanente Northern California (KPNC).
Detailed description
The study has three primary objectives: 1) learn what is required to create and sustain a care navigator workforce and document our experience hiring a care navigator for the study, 2) implement and evaluate the AURORA strategy within KPNC, and 3) refine and adapt the AURORA strategy for future Kaiser Permanente (KP) wide dissemination. The AURORA strategy centers on a care navigator who will proactively conduct three telemedicine visits tailored to Latinx adults with early onset type 2 diabetes (T2D, defined as age \<45 years). The AURORA strategy will conducted with the following five goals: 1) assessment of familiarity and use of T2D care within KP, 2) assessment of individual's self-management support needs, 3) motivational interviewing to support behavior change, 4) pragmatic skills training, including use of crucial technologies to support self-management, and 5) matching member's needs with existing KPNC T2D resources.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | AURORA Care Strategy | Participants will be invited to partake in three telemedicine visits with the care navigator during the months following diagnosis. The visits center around proactive and tailored T2D self-management support. |
Timeline
- Start date
- 2023-03-31
- Primary completion
- 2025-04-01
- Completion
- 2025-12-01
- First posted
- 2023-03-03
- Last updated
- 2024-05-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05754008. Inclusion in this directory is not an endorsement.